Mosquitoes may develop resistance to insecticide active ingredients (AI). Thus, mosquitoes should be tested for resistance to confirm efficacy of insecticide-based control, inform management decisions, and protect public and environmental health. Our objectives were to determine a baseline of resistance for six AIs used in mosquito control in the United States to assess how resistance differs between mosquito collection location, AI, and mosquito species (container-ovipositing Aedes and Culex that may oviposit in containers or other sources). Field-collected eggs from 26 mosquito populations of five different species or hybrid species (Aedes albopictus Say, Aedes triseriatus Say, Culex pipiens L., Culex quinquefasciatus Say, Culex pipiens/quinquefasciatus) were obtained from four regions across the United States. Centers for Disease Control and Prevention bottle bioassays were used to determine baseline resistance and susceptibility status for six AIs (bifenthrin, deltamethrin, etofenprox, malathion, permethrin, and phenothrin). World Health Organization guidelines were used to classify mosquitoes as susceptible (98-100% mortality at diagnostic time [DT]), possibly resistant (80-97% mortality at DT), or resistant (< 80% mortality at DT). Aedes spp. mosquitoes were less likely to exhibit resistance, compared with Culex spp. mosquitoes. A high degree of resistance to etofenprox and malathion was observed (4-26-fold greater resistance to these two AIs compared with the other examined AIs). Baseline data on resistance and susceptibility for mosquitoes exposed to commonly used insecticides may help us evaluate resistance trends and highlight the importance of assessing local resistance trends before insecticide-based control measures are implemented.
Mosquitoes exposed to sublethal doses of insecticides may be selected for resistance to insecticide active ingredients (AIs). Mosquitoes are exposed to AIs through agricultural, public/private mosquito control programs, homeowners, and other sources. Hence, mosquito control programs should routinely measure the resistance/susceptibility status of mosquito populations of public health concern. The objectives here were to determine resistance status for six AIs used in adult mosquito control in the United States to assess how resistance/susceptibility differs between AI, mosquito species (states where > 1 species collected), and between years (some populations sampled for 2 yr). Field-collected eggs from 21 mosquito populations of six different species or hybrid species (Aedes albopictus Skuse [Diptera: Culicidae], Aedes aegypti L. [Diptera: Culicidae], Culex nigripalpus Theobald, Culex pipiens L. [Diptera: Culicidae], Culex quinquefasciatus Say [Diptera: Culicidae], Cx. pipiens/quinquefasciatus) were obtained. Centers for Disease Control and Prevention bottle bioassays were used to assess the resistance/susceptibility status for six AIs (bifenthrin, deltamethrin, etofenprox, malathion, permethrin, and phenothrin). World Health Organization guidelines were used to classify mosquitoes as susceptible (98-100% mortality at diagnostic time [DT]), possibly resistant (80-97% mortality at DT), or resistant (<80% mortality at DT). Significant differences were observed in mosquito susceptibility/resistance between species and AIs. In states where both Aedes and Culex were collected, the odds of exhibiting resistance in Culex were 68-69 times higher than Aedes (Texas odds ratio: 69.30; 95% confidence interval: 5.86, 819.44; P = 0.001; North Carolina odds ratio: 67.99; 95% confidence interval: 15.21, 303.94; P < 0.0001). Some level of resistance was detected against all tested AIs in several mosquito populations and some varied between 2015 and 2016.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.